CAIRE Diagnostics is a subsidiary of CAIRE Inc., a leading supplier of oxygen therapy products. Our mission is Asthma Wellness. We pursue it with our Fenom Pro® Asthma Monitor.
Fenom Pro measures Fractional Exhaled Nitric Oxide (FeNO). FeNO is an established biomarker for airway inflammation. It’s measured with a 10-second breath test that is easier to perform than Peak Flow and FEV1. Use of FeNO for asthma management is reimbursed, and recommended by the American Thoracic Society and others.
Monitoring inflammation with Fenom Pro can help keep asthma under control, but access is low due to the small number of asthma specialists in the US. CAIRE Diagnostics is piloting an Asthma Wellness program in retail health, in order to bring better asthma control and quality of life to all communities.
For more information or to participate, contact Chili Hill at email@example.com.